Brief: China's Tasly Pharma, France's Pharnext plan JV in China

Pharnext SCA

09/05/2017 12:30

May 9 (Reuters) - Tasly Pharmaceutical Group Co Ltd 
 600535.SS  
    * Says unit plans to invest 20 million euros  ($21.79 
million) in Pharnext S.A. For 12.6 percent stake 
    * Says it and Pharnext plan to invest 200 million yuan to 
set up JV in China for technology innovation and product 
development 
 
 
    Source text in Chinese: http://bit.ly/2pZjp8U 
    Further company coverage:  600535.SS  
 
($1 = 0.9177 euros) 
 
 (Reporting by Hong Kong newsroom) 
 ((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441; 
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))